BioDrugs (2017) 31:287 DOI 10.1007/s40259-017-0236-3 ERRATUM Erratum to: A ‘Global Reference’ Comparator for Biosimilar Development 1 2 Christopher J. Webster Gillian R. Woollett Published online: 2 August 2017 Springer International Publishing AG 2017 Erratum to: BioDrugs DOI 10.1007/s40259-017-0227-4 The article ‘‘A ‘Global Reference’ Comparator for Biosim- ilar Development’’, written by Christopher J. Webster and Gillian R. Woollett, was originally published electronically on the publisher’s internet portal SpringerLink on 19 May 2017 without open access. With the authors’ decision to opt for Open Choice the copyright of the article changed on 01/08/2017 to The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Com- mons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, duplication, adap- tation, distribution and reproduction in any medium or for- mat, as long as you give appropriate credit to the original authors and the source, provide a link to the Creative Com- mons license and indicate if changes were made. The open access fee was funded by Avalere Health. The original article was corrected. The online version of the original article can be found under doi:10.1007/s40259-017-0227-4. & Gillian R. Woollett email@example.com BioApprovals, Acton, MA 01720, USA FDA Regulatory Strategy and Policy, Avalere Inc, 1350 Connecticut Avenue, NW, Suite 900, Washington, DC 20036, USA
BioDrugs – Springer Journals
Published: Aug 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera